Results 41 to 50 of about 1,940,460 (362)
Vaccines, 2021 We present a case of immune thrombocytopenia (ITP) induced by the chimpanzee adenovirus-vectored vaccine, without evidence of thrombosis, eight days after vaccine administration.
Po-Wei Liao +2 more
doaj +1 more source
Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia.
New England Journal of Medicine, 2021 BACKGROUND Immune thrombocytopenia is a rare autoimmune disorder with associated bleeding risk and fatigue. Recommended first-line treatment for immune thrombocytopenia is high-dose glucocorticoids, but side effects, variable responses, and high relapse ...
C. Bradbury +12 more
semanticscholar +1 more source
How I approach new onset thrombocytopenia
Platelets, 2020 Thrombocytopenia is a common reason for referral to hematologists in community and hospital practice. A broad differential diagnosis, combined with the potentially life-threatening nature of some presentations necessitates a rapid evaluation of the ...
Fiona Swain, Robert Bird
doaj +1 more source
Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine
Journal of Blood Medicine, 2021 The rollout of the SARS-CoV-2 vaccine is underway, and millions have already been vaccinated. At least 25 reports of “immune thrombocytopenia” (ITP) or “thrombocytopenia” following the Moderna or Pfizer vaccine have been added to the Vaccine Adverse ...
J. Helms +6 more
semanticscholar +1 more source
Immune thrombocytopenia and pregnancy [PDF]
Obstetric Medicine, 2011 Immune thrombocytopenia (ITP) is not infrequently encountered during reproductive years with an estimated incidence of 0.1–1 per 1000 pregnancies. An international consensus group recently re-defined ITP and outlined standardized response criteria and up-to-date investigation and management.
Susan Robinson, Srividhya Sankaran
openaire +2 more sources
Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review
SN Comprehensive Clinical Medicine, 2020 Immune thrombocytopenia, often known as immune thrombocytopenic purpura (ITP), has emerged as an important complication of COVID-19. A systematic review was done to analyze the clinical profile and outcomes in a total of 45 cases of new-onset ITP in ...
Sukrita Bhattacharjee, M. Banerjee
semanticscholar +1 more source
Exacerbation of immune thrombocytopenia following COVID‐19 vaccination
British Journal of Haematology, 2021 There is concern that COVID‐19 vaccination may adversely affect immune thrombocytopenia (ITP) patients. Fifty‐two consecutive chronic ITP patients were prospectively followed after COVID‐19 vaccination.
D. Kuter
semanticscholar +1 more source
American Society of Hematology 2019 guidelines for immune thrombocytopenia.
Blood Advances, 2019 BACKGROUND Despite an increase in the number of therapies available to treat patients with immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist physicians with the management of patients. OBJECTIVE These evidence-based
C. Neunert +16 more
semanticscholar +1 more source
Immune Thrombocytopenia: A Rare Presentation of Pulmonary Sarcoidosis
European Journal of Case Reports in Internal Medicine, 2021 Thrombocytopenia may be the initial presentation of sarcoidosis, which is a systemic granulomatous disorder. Various pathophysiological mechanisms have been identified. Immune thrombocytopenia often has a severe presentation but may respond favourably to
Mariana da Silva Leal +5 more
doaj +1 more source
Blood Advances, 2019 Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune thrombocytopenia (ITP). This article is an update of the International Consensus Report published in 2010.
D. Provan +21 more
semanticscholar +1 more source